Pictured: William Jarnagin
Cancer Guide
By Andrea Peirce, BA, Writer/Editor  |  Tuesday, February 25, 2014

Thanks to recent treatment advances, many people diagnosed with liver cancer today can expect to survive the disease. But experience counts.

Pictured: Oliver Zivanovic, Garrett Nash & Dennis Chi
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor  |  Friday, November 15, 2013

Memorial Sloan Kettering experts are leading investigations of a procedure called hyperthermic intraperitoneal chemotherapy, also known as HIPEC.

Pictured: Lee Krug
Cancer Guide
By Andrea Peirce, BA, Writer/Editor  |  Friday, October 11, 2013

Memorial Sloan Kettering is recognized worldwide for its treatment of pleural and peritoneal mesothelioma.

Pictured: Dennis Chi & Richard Barakat
Q&A
By Allyson Collins, MS, Science Writer/Editor  |  Tuesday, March 12, 2013

Gynecology Service Chief Richard Barakat comments on a recent study indicating that women treated by more-experienced physicians receive the most-appropriate care for this aggressive form of cancer.

Pictured: Kenneth Yu
In the Clinic
By Media Staff  |  Tuesday, January 29, 2013

New research suggests that analyzing genetic changes found in the bloodstream may help doctors predict which chemotherapy regimens will work for some patients.

Pictured: Breast tumor treated with paclitaxel
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Friday, December 2, 2011

Recent findings by Memorial Sloan Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.

Center News

Stay Informed

Get the latest information about cancer care and research every month.